Pathological GH deficiency is characterized by a high risk cardiovascular profile [5–8], and similarly, in obese individuals, relatively low GH levels are associated with higher visceral fat [3], which in turn predisposes individuals to components of the metabolic syndrome [9, 10], including hyperlipidemia [10, 11] and insulin resistance [10, 12]. Here, GH1 is linked to hyperlipidemia.